No. |
Product Name |
CAS No. |
Spec |
Price |
|
| LP-3597 |
Pizotyline malate ≥98% |
5189-11-7 |
| 1 g |
Inquiry |
| 5 g |
Inquiry |
| 10 g |
Inquiry |
|
|
| LP-4560 |
Proteolipid protein (139-151) ≥95 % |
|
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LP-5845 |
Polydatin 0.97 |
65914-17-2 |
| 250 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LP-6850 |
Prolactin-Releasing Peptide (1-31), human ≥98 % |
|
|
|
| LP-8270 |
Purvalanol A ≥98 % |
212844-53-6 |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LP-6977 |
Pyr-G-R-pNA ≥98 % |
|
| 1 mg |
Inquiry |
| 10 mg |
Inquiry |
|
|
| LP-9767 |
Pyriproxyfen ≥95% |
95737-68-1 |
| 5 g |
Inquiry |
| 25 g |
Inquiry |
| 100 g |
Inquiry |
|
|
| LP-9768 |
Pyronaridine Tetraphosphate ≥98 % |
76748-86-2 |
| 100 mg |
Inquiry |
| 250 mg |
Inquiry |
| 1 g |
Inquiry |
|
|
| LP-9770 |
Pyrrolostatin ≥98% |
144314-68-1 |
| 100 μg |
Inquiry |
| 1 mg |
Inquiry |
|
|
| LR-0250 |
Ranatensin ≥98% |
29451-71-6 |
| 1 mg |
Inquiry |
| 2 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LR-0251 |
Ranatensin R ≥98% |
70572-93-9 |
| 1 mg |
Inquiry |
| 2 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LR-1985 |
Reveromycin A ≥98% |
134615-37-5 |
| 100 g |
Inquiry |
| 5 x 100 g |
Inquiry |
|
|
| LR-2112 |
RFDS ≥98% |
|
|
|
| LR-2512 |
RGD ≥95% |
99896-85-2 |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
| 25 mg |
Inquiry |
|
|
| LR-2513 |
RGDS ≥95% |
91037-65-9 |
|
|
| LR-2514 |
RGDV ≥98% |
93674-99-8 |
| 5 mg |
Inquiry |
| 10 mg |
Inquiry |
| 25 mg |
Inquiry |
|
|
| LR-3374 |
Risedronic acid ≥97 % |
105462-24-6 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
| 250 mg |
Inquiry |
|
|
| LR-5661 |
Ropinirole hydrochloride ≥99 % |
91374-20-8 |
| 25 mg |
Inquiry |
| 100 mg |
Inquiry |
| 500 mg |
Inquiry |
|
|
| LR-8207 |
beta-Rubromycin ≥98 % |
27267-70-5 |
| 1 mg |
Inquiry |
| 5 mg |
Inquiry |
|
|
| LS-0048 |
Salicin ≥98 % |
138-52-3 |
|
|
